Your browser doesn't support javascript.
loading
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis.
Bhattacharyya, Swati; Wang, Wenxia; Tamaki, Zenshiro; Shi, Bo; Yeldandi, Anjana; Tsukimi, Yasuhiro; Yamasaki, Masashi; Varga, John.
Affiliation
  • Bhattacharyya S; Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States.
  • Wang W; Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States.
  • Tamaki Z; Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States.
  • Shi B; Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States.
  • Yeldandi A; Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States.
  • Tsukimi Y; Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Yamasaki M; Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Varga J; Northwestern Scleroderma Program, Feinberg School of Medicine, Chicago, IL, United States.
Front Immunol ; 9: 2434, 2018.
Article in En | MEDLINE | ID: mdl-30405628

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Fibrosis / Scleroderma, Systemic / Skin / Toll-Like Receptor 4 / Fibroblasts Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Front Immunol Year: 2018 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Fibrosis / Scleroderma, Systemic / Skin / Toll-Like Receptor 4 / Fibroblasts Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Front Immunol Year: 2018 Document type: Article Affiliation country: Estados Unidos